Cognitive Behavioral Therapy for Insomnia in the Digital Age
1Department of Psychiatry, Gil Medical Center, College of Medicine, Gachon University, 21, Namdong-daero 774 beon-gil, Namdong-gu, Incheon, 21565, Republic of Korea. kangsg@gachon.ac.kr.
Advances in Experimental Medicine and Biology
|November 10, 2019
Summary
Cognitive behavioral therapy for insomnia (CBT-I) offers effective treatment but faces access barriers. Digital CBT-I, including mobile and internet-based options, shows promise but requires improved technology and reduced dropout rates for wider adoption.
Area of Science:
- Sleep Medicine
- Digital Health
- Behavioral Therapy
Background:
- Cognitive behavioral therapy for insomnia (CBT-I) is the gold standard treatment for insomnia.
- Limited availability of trained therapists and high clinical costs hinder widespread CBT-I adoption.
- Digital health solutions, including internet and mobile CBT-I, are emerging to address these accessibility issues.
Purpose of the Study:
- To review the current landscape and future directions of digital CBT-I.
- To highlight the need for technological advancements in digital sleep interventions.
- To emphasize the importance of reducing dropout rates in digital CBT-I programs.
Main Methods:
- Review of recent research on internet-based and mobile CBT-I.
- Analysis of studies utilizing wearable devices for sleep-wake estimation.
- Evaluation of treatment effects and dropout rates in digital CBT-I.
Main Results:
- Digital CBT-I interventions demonstrate favorable treatment effects for insomnia.
- High dropout rates remain a significant challenge in digital CBT-I.
- Wearable devices show potential for sleep-wake estimation, but accuracy needs improvement.
Conclusions:
- Further research and development are crucial for fully automated digital CBT-I.
- Enhancing sleep tracker accuracy and conducting validation studies are essential.
- Optimizing digital CBT-I delivery is key to maximizing treatment effectiveness for future insomnia patients.
Related Concept Videos
Insomnia
371
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
371
Management of Insomnia
473
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
473
Insufficient Sleep and Sleep Deprivation
790
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
790
Substance Use Disorders Affecting Sleep
349
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
349
REM Sleep Behavior Disorder
1.2K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
1.2K
CNS Depressants: Barbiturates and Benzodiazepines
1.1K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.1K


